XML 23 R12.htm IDEA: XBRL DOCUMENT v3.21.1
Cash, Cash Equivalents and Marketable Securities
3 Months Ended
Mar. 31, 2021
Investments Debt And Equity Securities [Abstract]  
Cash, Cash Equivalents and Marketable Securities

Note 5. Cash, Cash Equivalents and Marketable Securities

The following tables summarize the Company’s cash, cash equivalents and marketable securities as of March 31, 2021 and December 31, 2020.


As of March 31, 2021

 

 

 

Amortized Cost

 

 

Unrealized Gain

 

 

Unrealized (Loss)

 

 

Fair Value

 

Cash and cash equivalents

 

$

9,064,385

 

 

$

 

 

$

 

$

9,064,385

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury Bonds

 

$

16,388,386

 

 

$

 

 

$

(47

)

 

$

16,388,339

 

Total marketable securities

 

$

16,388,386

 

 

$

 

 

$

(47

)

 

$

16,388,339

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total cash, cash equivalents, and marketable securities

 

$

25,452,771

 

 

$

 

 

$

(47

)

 

$

25,452,724

 

 

As of December 31, 2020

 

 

 

Amortized Cost

 

 

Unrealized Gain

 

 

Unrealized (Loss)

 

 

Fair Value

 

Cash and cash equivalents

 

$

4,241,937

 

 

$

 

 

$

 

$

4,241,937

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury Bonds

 

$

18,388,970

 

 

$

 

 

$

(2,810

)

 

$

18,386,160

 

Total marketable securities

 

$

18,388,970

 

 

$

 

 

$

(2,810

)

 

$

18,386,160

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total cash, cash equivalents, and marketable securities

 

$

22,630,907

 

 

$

 

 

$

(2,810

)

 

$

22,628,097